Schedule 13G ownership disclosure

Immunome Inc

Common Stock, $0.0001 Par Value · CUSIP: 45257U108

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Redmile Group, LLC

    Shares: 5,361,187.00 · Class: 6.2%

  • Jeremy C. Green

    Shares: 5,361,187.00 · Class: 6.2%

  • Redmile Biopharma Investments III, L.P.

    Shares: 3,879,415.00 · Class: 4.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-049702
Form type
SCHEDULE 13G/A
Filer
Immunome Inc.
CIK
CIK 1472012
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub